NK2 tachykinin receptor selective antagonist.
(Modifications: Leu-5 - Leu-6 = Leu-CH2N(CH3)-Leu, Cyclized)
|Storage||Desiccate at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solubility||Soluble to 0.50 mg/ml in acetonitrile / water|
Preparing Stock Solutions
The following data is based on the product molecular weight 745. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.34 mL||6.71 mL||13.42 mL|
|5 mM||0.27 mL||1.34 mL||2.68 mL|
|10 mM||0.13 mL||0.67 mL||1.34 mL|
|50 mM||0.03 mL||0.13 mL||0.27 mL|
References are publications that support the products' biological activity.
Black et al (1992) Tachykinin receptors in rabbit airways - characterization by functional, autoradiographic and binding studies. Br.J.Pharmacol. 107 429 PMID: 1384914
Maggi et al (1993) MEN 10,573 and MEN 10,612, novel cyclic pseudopeptides which are potent tachykinin NK-2 receptor antagonists. Regul.Pept. 47 151 PMID: 8234901
If you know of a relevant reference for MDL 29,913, please let us know.
View Related Products by Product Action
Keywords: MDL 29,913, supplier, Selective, NK2, antagonists, Tachykinin, Receptors, Neurokinin, MDL29913, NK2, Receptor, NK2, Receptor, Tocris Bioscience
Citations for MDL 29,913
Citations are publications that use Tocris products.
Currently there are no citations for MDL 29,913. Do you know of a great paper that uses MDL 29,913 from Tocris? If so please let us know.
MDL 29,913 Reviews
Average Rating:(Based on 0 Reviews)
Literature in this Area
Peptides Involved in Appetite Modulation Scientific Review
Written by Sonia Tucci, Lynsay Kobelis and Tim Kirkham, this review provides a synopsis of the increasing number of peptides that have been implicated in appetite regulation and energy homeostasis; putative roles of the major peptides are outlined and compounds available from Tocris are listed.
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.